Preparing data for you could take a moment.
Thank you for your patience.
It is worth the wait.
We frequently make our website faster.
Cannabis Stock Destroyed by 81% Decline on Clinical Trial Failure

Cannabis Stock Destroyed by 81% Decline on Clinical Trial Failure

Intec Pharma Ltd. is a tiny company in the space of pot stocks, doing clinical research involving cannabis. But one of their drugs failed a Stage III clinical trial. Intec’s stock got crushed and lost 81 percent of its value. Death of A Cannabis Stock Dream Intec has three drugs in its pipeline, including cannabis […]

The post Cannabis Stock Destroyed by 81% Decline on Clinical Trial Failure appeared first on CCN Markets

CCN Markets

<!–
–>
Source

Tesla Warning Ahead of Q2 Earnings as Analyst Downgrades Stock

Tesla Warning Ahead of Q2 Earnings as Analyst Downgrades Stock

Tesla earnings are almost here and the electric vehicle maker’s stock has been dealt another blow. Roth Capital Partners has downgraded Tesla stock from buy to hold, as analyst Craig Irwin believes that the current risk-reward ratio seems “well balanced at current levels.” Irwin told MarketWatch that Tesla is on a “viable path for meeting […]

The post Tesla Warning Ahead of Q2 Earnings as Analyst Downgrades Stock appeared first on CCN Markets

CCN Markets

<!–
–>
Source